Shuttle Pharmaceuticals Holdings, Inc. Common Stock
SHPH US8256932034
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Brown Milton O |
0.46 USD |
2,921 Sold |
1,353 USD |
13/12/2023 | 13/12/2023 |
Jacobs Bette O |
0.46 USD |
4,157 Sold |
1,926 USD |
13/12/2023 | 13/12/2023 |
Senanayake Chris O |
1.61 USD |
1,626 Sold |
2,610 USD |
29/12/2022 | 29/12/2022 |